MediWound Ltd.
MDWD · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.69 | 0.19 | -0.10 |
| FCF Yield | -3.24% | -3.15% | -1.27% | -2.61% |
| EV / EBITDA | -34.86 | -26.53 | -12.05 | -40.21 |
| Quality | ||||
| ROIC | -14.79% | -11.15% | -13.05% | -10.36% |
| Gross Margin | 23.51% | 18.66% | 15.46% | 15.55% |
| Cash Conversion Ratio | 0.98 | 0.43 | 5.66 | 0.42 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.71% | -8.58% | -9.46% | -8.61% |
| Free Cash Flow Growth | -34.25% | -107.49% | 50.63% | 25.47% |
| Safety | ||||
| Net Debt / EBITDA | 4.58 | 6.54 | 0.17 | 0.00 |
| Interest Coverage | -0.76 | 0.00 | 0.00 | -0.98 |
| Efficiency | ||||
| Inventory Turnover | 1.14 | 0.90 | 1.83 | 1.22 |
| Cash Conversion Cycle | 65.23 | 78.28 | 64.59 | 106.94 |